Cerora

Cerora, founded in 2013 and headquartered in Bethlehem, Pennsylvania, is a private diagnostics company targeting the significant unmet need in objective brain injury assessment. Its core technology, the Borealis biosensor platform, integrates multiple data sources within a challenge paradigm to move beyond subjective symptom reporting for conditions like concussion. The company is in the development and regulatory phase, building a team with neurology and engineering expertise to bring its portable diagnostic tool to clinicians.

The Borealis biosensor platform integrates multiple data sources within a challenge paradigm to provide objective, real-time assessment of brain function. It is a portable system supported by cloud-based infrastructure, designed to increase diagnostic accuracy for conditions like concussion.

The objective neurodiagnostic space for concussion is competitive, with several companies developing technologies based on EEG, eye-tracking, balance, and blood biomarkers. Cerora's differentiation lies in its multi-sensor, challenge-paradigm approach, but it must prove clinical utility and ease of use to gain market share.